Matches in Wikidata for { <http://www.wikidata.org/entity/Q73700239> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q73700239 description "artículu científicu espublizáu en xunetu de 2003" @default.
- Q73700239 description "im Juli 2003 veröffentlichter wissenschaftlicher Artikel" @default.
- Q73700239 description "scientific article published on 01 July 2003" @default.
- Q73700239 description "wetenschappelijk artikel" @default.
- Q73700239 description "наукова стаття, опублікована в липні 2003" @default.
- Q73700239 name "Association between thrombin-activatable fibrinolysis inhibitor (TAFI) and clinical outcome in patients with unstable angina pectoris" @default.
- Q73700239 name "Association between thrombin-activatable fibrinolysis inhibitor" @default.
- Q73700239 type Item @default.
- Q73700239 label "Association between thrombin-activatable fibrinolysis inhibitor (TAFI) and clinical outcome in patients with unstable angina pectoris" @default.
- Q73700239 label "Association between thrombin-activatable fibrinolysis inhibitor" @default.
- Q73700239 prefLabel "Association between thrombin-activatable fibrinolysis inhibitor (TAFI) and clinical outcome in patients with unstable angina pectoris" @default.
- Q73700239 prefLabel "Association between thrombin-activatable fibrinolysis inhibitor" @default.
- Q73700239 P1433 Q73700239-6890155B-B7A1-4FF1-A18D-D014E281D192 @default.
- Q73700239 P1476 Q73700239-04DFB027-D9D1-49B8-8638-8B05BA044071 @default.
- Q73700239 P2093 Q73700239-00EE0264-B4F7-45FA-BCC4-24E2A2E46D66 @default.
- Q73700239 P2093 Q73700239-373BBB74-E34A-4050-8720-A8AC30BFCD2D @default.
- Q73700239 P2093 Q73700239-404F877B-71C0-4D3F-B6D7-660612B489D9 @default.
- Q73700239 P2093 Q73700239-4692E1B2-8FF1-4345-83EF-B0685EEEC3BB @default.
- Q73700239 P2093 Q73700239-F88EF012-2914-4B06-B3CB-441E7A76C2C8 @default.
- Q73700239 P304 Q73700239-7AE48715-1CC6-4CC2-9B05-C77157AD5FD2 @default.
- Q73700239 P31 Q73700239-D4D5CA42-7A9D-498E-A0A0-56420EAC6029 @default.
- Q73700239 P433 Q73700239-D7581F67-0190-4356-9092-162D6577B2A7 @default.
- Q73700239 P478 Q73700239-9B8E9435-5A8E-4789-8198-3A742A2E97B7 @default.
- Q73700239 P50 Q73700239-1CC2C012-2975-4D36-8F41-AA8AC4167958 @default.
- Q73700239 P577 Q73700239-B3A09B4D-5392-4502-953C-B44781551B82 @default.
- Q73700239 P698 Q73700239-879A28D3-9965-4D1B-9870-BFD0F5A22E75 @default.
- Q73700239 P921 Q73700239-1819DD13-A933-452D-B2E7-48FEB450C697 @default.
- Q73700239 P698 12876631 @default.
- Q73700239 P1433 Q15724413 @default.
- Q73700239 P1476 "Association between thrombin-activatable fibrinolysis inhibitor (TAFI) and clinical outcome in patients with unstable angina pectoris" @default.
- Q73700239 P2093 "Cornelis Kluft" @default.
- Q73700239 P2093 "Frank W G Leebeek" @default.
- Q73700239 P2093 "Geert-Jan Brouwers" @default.
- Q73700239 P2093 "Michael W T Tanck" @default.
- Q73700239 P2093 "Moniek P M de Maat" @default.
- Q73700239 P304 "92-100" @default.
- Q73700239 P31 Q13442814 @default.
- Q73700239 P433 "1" @default.
- Q73700239 P478 "90" @default.
- Q73700239 P50 Q64858750 @default.
- Q73700239 P577 "2003-07-01T00:00:00Z" @default.
- Q73700239 P698 "12876631" @default.
- Q73700239 P921 Q2032041 @default.